OOIR: Observatory of International Research

Papers

(The H4-Index of Archives of Pharmacal Research is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Mouse models of nonalcoholic steatohepatitis and their application to new drug development	234
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo	167
Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process	91
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation	77
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy	69
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities	63
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer	61
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways	57
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration	56
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin	53
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis	46
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway	41
Impact of binge drinking on alcoholic liver disease	40
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight	40
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats	39
Germacrane and humulane sesquiterpenes from the roots and rhizomes of Valeriana officinalis var. latifolia and their anti-inflammatory and anti-influenza virus activities	38
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions	38
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis	37
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis	37
Non-alcoholic fatty liver disease and liver secretome	33
The role and application of transcriptional repressors in cancer treatment	32
Minor structural changes, major functional impacts: posttranslational modifications and drug targets	31
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations	31
Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes	29
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes	28

Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation	27
Ginsenoside Rh1 inhibits tumor growth in MDA-MB-231 breast cancer cells via mitochondrial ROS and ER stress-mediated signaling pathway	27
Triterpenoids from Dysoxylum genus and their biological activities	27